ArticlePharmaceuticals (Basel, Switzerland)2025
Physicochemical Properties and Molecular Insights of Favipiravir and Roflumilast Solid Dispersions for COVID-19 Treatment.
Abdul Rauf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.